AfricaRegulatory
African Pharmaceutical Regulatory Intelligence
AMOXICILLIN & POTASSIUM CLAVULANATE
25 registrations across 5 African markets— 10 active
Markets with AMOXICILLIN & POTASSIUM CLAVULANATE
Recent registrations
| Brand / Product | Market | Holder | Status | Expires |
|---|---|---|---|---|
| Augmentin BD SF suspension Suspension for Oral Use | 🇿🇲Zambia | GlaxoSmithKline South Africa (Pty) Ltd | active | Mar 2030 |
| CLAVUMOCCID-500 POWDER FOR ORAL SUSPENSION | 🇷🇼Rwanda | Medicef Pharma | active | Jan 2030 |
| Bactized 625 TABLETS Film-Coated Tablet | 🇰🇪Kenya | Zawadi Healthcare Ltd | active | Jan 2027 |
| BACTIZED SYRUP 228.50 Oral Suspension | 🇰🇪Kenya | Zawadi Healthcare Ltd | active | Jan 2027 |
| REDAMOX_625 625MG TABLET TABLET | 🇲🇼Malawi | — | expired | Mar 2025 |
| LABCLAV_625 625MG TABLET TABLET | 🇲🇼Malawi | — | expired | Mar 2025 |
| REDAMOX_375 375MG TABLET TABLET | 🇲🇼Malawi | — | expired | Mar 2025 |
| CLEDOMOX_228.5_DT 228.5MG DISPESIBLE TABLET DISPESIBLE TABLET | 🇲🇼Malawi | — | expired | Mar 2025 |
| LABCLAV_1G 1G TABLET TABLET | 🇲🇼Malawi | — | expired | Mar 2025 |
| CLEDOMOX>625 625MG TABLET TABLET | 🇲🇼Malawi | — | expired | Mar 2025 |
| MOXILEB_CV_375 375MG TABLET TABLET | 🇲🇼Malawi | — | expired | Mar 2025 |
| MOXILEB_CV_625 625MG TABLET TABLET | 🇲🇼Malawi | — | expired | Mar 2025 |
| CLEDOMOX=228.5 228.5MG SUSPENSION SUSPENSION | 🇲🇼Malawi | — | expired | Mar 2025 |
| BACTOCLAV_1000 1000MG TABLET TABLET | 🇲🇼Malawi | — | expired | Mar 2024 |
| SPOTCLAV_625 625MG TABLET TABLET | 🇲🇼Malawi | — | expired | Mar 2024 |
| SPOTCLAV_OS 156MG/5ML SUSPENSION SUSPENSION | 🇲🇼Malawi | — | expired | Mar 2024 |
| CLEDOMOX_375 375MG TABLET TABLET | 🇲🇼Malawi | — | expired | Jun 2017 |
| MOXILEB_CV_156.25 156.25MG TABLET TABLET | 🇲🇼Malawi | — | expired | Jun 2017 |
| BACTOCLAV_562.5 562.5MG TABLET TABLET | 🇲🇼Malawi | — | expired | Jun 2015 |
| AMOXICILLIN +
POTASSIUM
CLAVULANATE ORAL SOLID
ORDINARY FILM-
COATED TABLETS | 🇺🇬Uganda | CACHET PHAMACUITICAL S PVT LTD | active | — |
| AMOXICILLIN +
POTASSIUM
CLAVULANATE PARENTERAL
ORDINARY DRY
VIALS | 🇺🇬Uganda | STRIDES PHARMA SCIENCE LIMITED | active | — |
| AMOXICILLIN +
POTASSIUM
CLAVULANATE PARENTERAL
ORDINARY DRY
VIALS | 🇺🇬Uganda | STRIDES PHARMA SCIENCE LIMITED | active | — |
| AMOXICILLIN +
POTASSIUM
CLAVULANATE ORAL SOLID
ORDINARY FILM-
COATED TABLETS | 🇺🇬Uganda | CACHET PHAMACUITICAL S PVT LTD | active | — |
| AMOXICILLIN +
POTASSIUM
CLAVULANATE ORAL SOLID
ORDINARY FILM-
COATED
TABLETS | 🇺🇬Uganda | CACHET PHAMACUITICAL S PVT LTD | active | — |
| AMOXICILLIN +
POTASSIUM
CLAVULANATE ORAL SOLID
ORDINARY FILM-
COATED
TABLETS | 🇺🇬Uganda | CACHET PHAMACUITICAL S PVT LTD | active | — |
AMOXICILLIN & POTASSIUM CLAVULANATE in Africa — Regulatory Overview
AMOXICILLIN & POTASSIUM CLAVULANATE is registered across 5 African markets with 25 total product registrations on file. Data is sourced directly from official national drug regulatory authorities including Malawi, Uganda, Kenya, Rwanda and 1 more. AfricaRegulatory refreshes this data daily from official government sources.
Of the 25 registrations, 10 (40%) are currently active. Regulatory affairs teams use AfricaRegulatory to track registration expiry dates, identify market incumbents, and monitor approval status across African markets without manual monitoring of each national regulator.